logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Gaps in antidepressant prescribing in primary care in the United Kingdom.

    Article - En anglais

    An important determinant for achieving efficacy results in clinical practice comparable to those demonstrated in clinical trials is whether or not patients take their medication as prescribed.

    Recent studies have shown that 30-60% of patients do not take their medications as prescribed.

    Gaps between antidepressant prescriptions raise questions about the possibility of periods of nonadherence to medication in clinical practice.

    The purpose of conducting this study was to assess the likelihood of experiencing a gap of>15 days between antidepressant prescriptions for patients with a depression-related diagnosis and to assess whether this likelihood varied across different antidepressants with tricyclic antidepressants and selective serotonin reuptake inhibitors.

    Episodes of antidepressant treatment were constructed using the Doctors'Independent Network general practitioner medical records database.

    For all antidepressant agents considered, approximately 50% of patients had a gap between prescriptions and 15-25% of patients had a gap of>15 days between prescriptions.

    A significant proportion of patients in a general practitioner setting in the UK have gaps recorded of>15 days between antidepressant prescriptions.

    Gaps between prescriptions raise the question of whether patients may be at risk for clinical consequences associated with nonadherence to therapy, such as reduced effectiveness or treatment interruption symptomatology.

    Mots-clés Pascal : Psychotrope, Antidépresseur, Composé tricyclique, Inhibiteur recapture, Sérotonine, Etude comparative, Trouble humeur, Homme, Observance médicamenteuse, Etat dépressif, Prescription médicale, Traitement, Chimiothérapie, Arrêt traitement, Royaume Uni, Europe, Soin santé primaire

    Mots-clés Pascal anglais : Psychotropic, Antidepressant agent, Tricyclic compound, Reuptake inhibitor, Serotonin, Comparative study, Mood disorder, Human, Drug compliance, Depression, Medical prescription, Treatment, Chemotherapy, Treatment withdrawal, United Kingdom, Europe, Primary health care

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0064558

    Code Inist : 002B02B02. Création : 31/05/1999.